Community-acquired Clostridium difficile infection in Serbian pediatric population

Carriage of Clostridium ( C. ) difficile in the intestinum of children, as well as its role in the disease (diarrhea) onset, is still controversial. The aim of this study is to investigate the community-acquired Clostridium difficile infection (CA-CDI) in Serbian pediatric population and to describe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical microbiology & infectious diseases 2018-06, Vol.37 (6), p.1061-1069
Hauptverfasser:	Predrag, Stojanović, Branislava, Kocić, Nikola, Stojanović, Niko, Radulovic, Zorica, Stojanović-Radić, Stanković-Đorđević, Dobrila
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use Antibiotics Bacteria Biomedical and Life Sciences Biomedicine Case-Control Studies Cephalosporins Cephalosporins - adverse effects Cephalosporins - therapeutic use Child Child, Preschool Children Clostridium difficile Clostridium difficile - drug effects Clostridium difficile - isolation & purification Clostridium Infections - drug therapy Clostridium Infections - epidemiology Clostridium Infections - microbiology Communities Community-Acquired Infections - drug therapy Community-Acquired Infections - epidemiology Community-Acquired Infections - microbiology Crohn's disease Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Data processing Diarrhea Diarrhea - microbiology Disease Female Humans Infant Internal Medicine Laxatives Leukemia Male Mathematical models Medical Microbiology Original Article Pediatrics Penicillins - adverse effects Penicillins - therapeutic use Population (statistical) Prospective Studies Regression models Retrospective Studies Risk analysis Risk Factors Serbia - epidemiology Statistical analysis Statistical models Toxins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!